Bristol Myers Squibb Settles Medicaid Rebate Suit For $75M
By Matthew Santoni (April 1, 2021, 7:04 PM EDT) -- Bristol Myers Squibb has agreed to pay $75 million to settle a whistleblower's False Claims Act suit over claims it shorted its payments to government insurance programs, Deputy U.S. Attorney Louis Lappen announced from Philadelphia Thursday.
The settlement ends claims that Bristol Myers paid less than it owed for dozens of drugs under the Medicaid Drug Rebate Program, where a drugmaker pays states incentives for their Medicaid programs to cover its products, by reducing what it told the state and federal governments the average prices were for the covered drugs.
"The Department of Justice is committed to ensuring that pharmaceutical manufacturers...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!